Investor Presentaiton
Leading global and local market positions in attractive
high-growth markets* (2/2)
eurofins
Eurofins
position
Testing for
Pharma/Biotech/Agrosciences
N°1 to N°3*
worldwide
Start 2000-2005
Total
market
size
estimate*
~ € 6bn
Food & Feed Testing
Environment Testing
N 1 worldwide
N°1*
worldwide
Start 1987
~ € 4bn
N 1 Worldwide
N°1*
worldwide
Start 2000
~ € 5bn
Clinical Diagnostics
Start-Up
Start 2014
€ 312bn** by 2025
Eurofins' focus Genomics/ Esoteric
Testing: € 5-10bn*
Eurofins
ranking
N 1 Worldwide in Pharma Products Testing
N 1 Worldwide in Discovery Pharmacology
Services
N 1 Worldwide in Agroscience CRO
services
Among top 5 global providers of central
laboratory and genomic services
N 1 or 2 in most segments/ countries in
Europe and the USA
N 1 in the USA
N 1 in Europe
N 1 in Germany
N 1 in France
N 1 in Nordics/Scandinavia
N 1 in Benelux
N 1 in the UK & Ireland
N 1 in Spain
N 1 in Brazil
N
1 in Agro Testing EU
N 1 in the USA
N 1 in Europe
N 1 in Germany
N 1 in France
N 1 in Nordics/Scandinavia
N 1 in Ireland
N 1 in Benelux
N 1 in Taiwan
N
2 in Spain
N 2 in Japan
Establishing leadership in targeted higher-
niche
growth innovative
areas (e.g.
genomics, infectious diseases, etc.) of the
clinical testing market, mainly in the U.S.
and Europe, as well as market access
through local laboratories in many large
markets worldwide to distribute advanced
tests.
*Only includes the outsourced part of the market. Estimate to the best of Eurofins' knowledge, based on data available to the Group
**Global Market Insights, August 20, 2019 (2025 market size estimate of USD 350bn converted at 31/12/2019 USD/EUR exchange rate of 0.89)
31View entire presentation